NKMAX Co Ltd (182400)

KOSDAQ
25,100
-1,500(-5.64%)
  • Volume:
    3,447,666
  • Bid/Ask:
    25,000/25,100
  • Day's Range:
    24,500 - 29,150

182400 Overview

Prev. Close
26,600
Day's Range
24,500-29,150
Revenue
11.96B
Open
26,200
52 wk Range
11,800-30,100
EPS
-1,438.56
Volume
3,447,666
Market Cap
981.06B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
683,078
P/E Ratio
-
Beta
1.06
1-Year Change
119.16%
Shares Outstanding
36,812,604
Next Earnings Date
Nov 11, 2021
What is your sentiment on NKMAX Co Ltd?
or
Vote to see community's results!

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellNeutralBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Buy
SummaryStrong SellStrong SellSellStrong BuyStrong Buy

NKMAX Co Ltd Company Profile

NKMAX Co Ltd Company Profile

Employees
86

NKMAX Co., Ltd., formerly ATGen, is a Korea-based company principally engaged in the research, development, manufacturing and supply of biological products. The Company is involved in the production and sale of recombinant proteins, monoclonal antibodies, NK cell activity test kits, cell therapy products, and in the provision of other related services. The NK cell activity test kits are provided under the name of NK Vue. The Company distributes its products within domestic market and to overseas markets.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.